Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

被引：0
|
作者：
Ma, Liya [1 ]
Yang, Wenli [1 ]
Zhou, Xinping [1 ]
Ye, Li [1 ]
Xu, Gaixiang [1 ]
Hu, Chao [1 ]
Luo, Yingwan [1 ]
Yang, Chunmei [1 ]
Ge, Zheng [2 ]
Tong, Hongyan [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Safety and efficacy exploration of intraperitoneal perfusion of PD-1 monoclonal antibody for patients with primary liver cancer with malignant ascites: A prospective, single-arm, phase Ib clinical trial
    Chen, Chao
    Li, Zixiong
    Yao, Anlong
    Wang, Sizhen
    Huang, Yong
    Wang, Jing
    Liu, Xiufeng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
    Mei, Heng
    Chen, Xiequn
    Zhou, Jianfeng
    Luo, Jianmin
    Shi, Qingzhi
    Liu, Jing
    Wu, Depei
    Chen, Guoan
    Tai, Yanfei
    Xiong, Junye
    Zou, Jianjun
    Hu, Yu
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [43] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
    Qiao, Qian
    Han, Chun
    Ye, Sisi
    Li, Juan
    Shao, Guoliang
    Bai, Yuxian
    Xu, Aibing
    Sun, Meili
    Wang, Wei
    Wu, Jian
    Huang, Ming
    Song, Lijie
    Huang, Luke
    Liu, Ting
    Liu, Wei
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Michelle
    Bai, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
    Jabbour, Elias
    Short, Nicholas J.
    Jain, Nitin
    Thompson, Philip A.
    Kadia, Tapan M.
    Ferrajoli, Alessandra
    Huang, Xuelin
    Yilmaz, Musa
    Alvarado, Yesid
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Macaron, Walid
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop
    LANCET HAEMATOLOGY, 2022, 9 (12): : E878 - E885
  • [45] Efficacy and safety of JMT103 in patients with giant cell tumor of bone: A multicenter, single-arm, open-label, phase Ib/II study.
    Niu, Xiaohui
    Wei, Feng
    Tu, Chongqi
    Huang, Gang
    Bi, Wenzhi
    Li, Jianmin
    Yao, Weitao
    Zhang, Xiaojing
    Shen, Jingnan
    Zhang, Guochuan
    Yan, Wangjun
    Yang, Jilong
    Lin, Jianhua
    Ye, Zhaoming
    Wang, Dong
    Guo, Zheng
    Tong, Zhichao
    Zhou, Yuhong
    Xu, Hairong
    Li, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial
    Gao, Ming
    Zhang, Xia
    Yan, Huan
    Zhao, Yan
    Yuan, Fang
    Sun, Decong
    Yang, Xuejiao
    Ju, Yanfang
    Wang, Lijie
    Tao, Haitao
    Tian, Luyuan
    Zhao, Changhong
    Ma, Junxun
    Hu, Yi
    Liu, Zhefeng
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [47] Anlotinib for patients with newly diagnosed glioblastoma with unmethylated MGMT promoter: An open-label, single-center, phase 2 clinical trial.
    Yang, Kunyu
    Wu, Bian
    Zhang, Zhanjie
    Peng, Gang
    Huang, Jing
    Hong, Xiaohua
    Ding, Qian
    Shi, Liangliang
    Wang, Xuan
    Zhao, Hongyang
    Jiang, Xiaobing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Optimized Rabbit Antithymocyte Globulin Protocol Plus Sequential Cyclosporine and Levamisole Regimen for Newly Diagnosed Severe Aplastic Anemia: A Single-Arm, SingleCentre, Prospective, Phase 2 Trial
    Ge, Meili
    Huo, Jiali
    Ren, Xiang
    Huang, Jinbo
    Wang, Min
    Nie, Neng
    Zhang, Jing
    Jin, Peng
    Mi, Yingchang
    Shao, Yingqi
    Zheng, Yizhou
    BLOOD, 2023, 142
  • [49] A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma
    Huang, Huiying
    Zhang, Hua
    Cao, Baoshan
    THORACIC CANCER, 2024, 15 (05) : 427 - 433
  • [50] Efficacy and safety of disitamab vedotin combined with gemcitabine as neoadjuvant therapy for muscle-invasive bladder cancer: A multi-center, single-arm, phase II trial
    Yang, C.
    Huang, H.
    Zeng, X.
    Dai, H.
    Zhou, G.
    Wang, S.
    Hu, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1148
12345